Journal Article
I. Koychev, Galna, B., Zetterberg, H., Lawson, J., Zamboni, G., Ridha, B. H., Rowe, J. B., Thomas, A., Howard, R., Malhotra, P., Ritchie, C., Lovestone, S., and Rochester, L.,
“Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.”,
J Alzheimers Dis, vol. 65, no. 4, pp. 1377-1383, 2018.
L. Ordoñez-Gutierrez, Fernandez-Perez, I., Herrera, J. Luis, Anton, M., Benito-Cuesta, I., and Wandosell, F.,
“AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 645-56, 2016.
H. Bielarczyk, Jankowska-Kulawy, A., Hofling, C., Ronowska, A., Gul-Hinc, S., Rossner, S., Schliebs, R., Pawelczyk, T., and Szutowicz, A.,
“AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.”,
J Alzheimers Dis, 2015.
S. Sindi, Ngandu, T., Hovatta, I., Kåreholt, I., Antikainen, R., Hänninen, T., Levälahti, E., Laatikainen, T., Lindström, J., Paajanen, T., Peltonen, M., Khalsa, D. Singh, Wolozin, B., Strandberg, T., Tuomilehto, J., Soininen, H., Kivipelto, M., and Solomon, A.,
“Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”,
J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
S. Sindi, Ngandu, T., Hovatta, I., Kåreholt, I., Antikainen, R., Hänninen, T., Levälahti, E., Laatikainen, T., Lindström, J., Paajanen, T., Peltonen, M., Khalsa, D. Singh, Wolozin, B., Strandberg, T., Tuomilehto, J., Soininen, H., Kivipelto, M., and Solomon, A.,
“Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”,
J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
K. Håkansson, Ledreux, A., Daffner, K., Terjestam, Y., Bergman, P., Carlsson, R., Kivipelto, M., Winblad, B., Granholm, A. - C., and Mohammed, A. Kadir H.,
“BDNF Responses in Healthy Older Persons to 35 Minutes of Physical Exercise, Cognitive Training, and Mindfulness: Associations with Working Memory Function.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 645-657, 2017.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. D. Dekker, Sacco, S., Carfi, A., Benejam, B., Vermeiren, Y., Beugelsdijk, G., Schippers, M., Hassefras, L., Eleveld, J., Grefelman, S., Fopma, R., Bomer-Veenboer, M., Boti, M., G Oosterling, D. E., Scholten, E., Tollenaere, M., Checkley, L., Strydom, A., Van Goethem, G., Onder, G., Blesa, R., Eulenburg, C. Zu, Coppus, A. M. W., Rebillat, A. - S., Fortea, J., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome.”,
J Alzheimers Dis, vol. 63, no. 2, pp. 797-819, 2018.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L.,
“Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L.,
“Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
I. Chalatsa, Arvanitis, D. A., Mikropoulou, E. V., Giagini, A., Papadopoulou-Daifoti, Z., Aligiannis, N., Halabalaki, M., Tsarbopoulos, A., Skaltsounis, L. A., and Sanoudou, D.,
“Beneficial Effects of Sideritis scardica and Cichorium spinosum against Amyloidogenic Pathway and Tau Misprocessing in Alzheimer's Disease Neuronal Cell Culture Models.”,
J Alzheimers Dis, vol. 64, no. 3, pp. 787-800, 2018.
C. Pimouguet, Le Goff, M., Wittwer, J., Dartigues, J. - F., and Helmer, C.,
“Benefits of Occupational Therapy in Dementia Patients: Findings from a Real-World Observational Study.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 509-517, 2017.
S. Wang, He, B., Hang, W., Wu, N. H., Xia, L., Wang, X., Zhang, Q., Zhou, X., Feng, Z., Chen, Q., and Chen, J.,
“Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.”,
J Alzheimers Dis, vol. 65, no. 4, pp. 1385-1400, 2018.
S. Wang, He, B., Hang, W., Wu, N. H., Xia, L., Wang, X., Zhang, Q., Zhou, X., Feng, Z., Chen, Q., and Chen, J.,
“Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.”,
J Alzheimers Dis, vol. 65, no. 4, pp. 1385-1400, 2018.
K. Le Guennec, Tubeuf, H., Hannequin, D., Wallon, D., Quenez, O., Rousseau, S., Richard, A. - C., Deleuze, J. - F., Boland, A., Frebourg, T., Gaildrat, P., Campion, D., Martins, A., and Nicolas, G.,
“Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient.”,
J Alzheimers Dis, vol. 62, no. 2, pp. 821-831, 2018.
M. Hülsemann, Zafiu, C., Kühbach, K., Lühmann, N., Herrmann, Y., Peters, L., Linnartz, C., Willbold, J., Kravchenko, K., Kulawik, A., Willbold, S., Bannach, O., and Willbold, D.,
“Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 79-88, 2016.
M. Hülsemann, Zafiu, C., Kühbach, K., Lühmann, N., Herrmann, Y., Peters, L., Linnartz, C., Willbold, J., Kravchenko, K., Kulawik, A., Willbold, S., Bannach, O., and Willbold, D.,
“Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 79-88, 2016.
S. R. Alves, Silva, Cda Cruz E., Martins, I., Henriques, A. Gabriela, and Silva, O. A. B. da Cru,
“A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.”,
J Alzheimers Dis, vol. 86, no. 4, pp. 1917-1933, 2022.
A. Russu, Samtani, M. N., Xu, S., Adedokun, O. J., Lu, M., Ito, K., Corrigan, B., Raje, S., Liu, E., H Brashear, R., Styren, S., and Hu, C.,
“Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”,
J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
A. M. Fernandez, Hervas, R., Dominguez-Fraile, M., Garrido, V. Navarro, Gomez-Gutierrez, P., Vega, M., Vitorica, J., Perez, J. J., and Aleman, I. Torres,
“Blockade of the Interaction of Calcineurin with FOXO in Astrocytes Protects Against Amyloid-β-Induced Neuronal Death.”,
J Alzheimers Dis, vol. 52, no. 4, pp. 1471-8, 2016.
C. Pappas, Small, B. J., Andel, R., Laczó, J., Pařízková, M., Ondrej, L., and Hort, J.,
“Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment.”,
J Alzheimers Dis, 2018.
A. Julian, Rioux-Bilan, A., Ragot, S., Krolak-Salmon, P., Berrut, G., Dantoine, T., Hommet, C., Hanon, O., Page, G., and Paccalin, M.,
“Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.”,
J Alzheimers Dis, vol. 63, no. 1, pp. 87-92, 2018.
A. Julian, Rioux-Bilan, A., Ragot, S., Krolak-Salmon, P., Berrut, G., Dantoine, T., Hommet, C., Hanon, O., Page, G., and Paccalin, M.,
“Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.”,
J Alzheimers Dis, vol. 63, no. 1, pp. 87-92, 2018.
D. A. Levine, Gross, A. L., Briceño, E. M., Tilton, N., Whitney, R., Han, D., Giordani, B. J., Sussman, J. B., Hayward, R. A., Burke, J. F., Elkind, M. S. V., Moran, A. E., Tom, S., Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., Sacco, R. L., Heckbert, S. R., Hughes, T. M., Lopez, O. L., Allen, N. Bai, and Galecki, A. T.,
“Blood Pressure and Later-Life Cognition in Hispanic and White Adults (BP-COG): A Pooled Cohort Analysis of ARIC, CARDIA, CHS, FOS, MESA, and NOMAS.”,
J Alzheimers Dis, vol. 89, no. 3, pp. 1103-1117, 2022.
] Year 